Livedo reticularis

Last updated
Livedo reticularis
Livedo reticularis of left leg.jpg
Livedo reticularis secondary to obscure severe infrarenal aortoiliac stenosis with severe transient lactic acidosis.
Specialty Dermatology, cardiology   OOjs UI icon edit-ltr-progressive.svg
Symptoms Purpura, mottling of the skin, blood clots, skin discoloration
Causes Autoimmune diseases, hyperlipidemia, poisons, drug abuse

Livedo reticularis is a common skin finding consisting of a mottled reticulated vascular pattern that appears as a lace-like purplish discoloration of the skin. [1] The discoloration is caused by reduction in blood flow through the arterioles that supply the cutaneous capillaries, resulting in deoxygenated blood showing as blue discoloration. This can be a secondary effect of a condition that increases a person's risk of forming blood clots, including a wide array of pathological and nonpathological conditions. Examples include hyperlipidemia, microvascular hematological or anemia states, nutritional deficiencies, hyper- and autoimmune diseases, and drugs/toxins.

Contents

The condition may be normal or related to more severe underlying pathology. [2] Its differential diagnosis is broadly divided into possible blood diseases, autoimmune (rheumatologic), cardiovascular diseases, cancers, and endocrine disorders. It can usually (in 80% of cases) be diagnosed by biopsy. [3]

It may be aggravated by exposure to cold, and occurs most often in the lower extremities. [4]

The condition's name derives from the Latin livere which means bluish, and reticular which refers to the net-like pattern. [5]

Causes

A number of conditions may cause the appearance of livedo reticularis:

Diagnosis

Livedo reticularis is diagnosed by its clinical appearance and history. No further test or examination confirms idiopathic livedo reticularis. However, further investigations may be undertaken where an underlying cause is suspected such as skin biopsies, or blood tests for antibodies associated with antiphospholipid syndrome or systemic lupus erythematosus. [46]

Treatment

Other than identifying and treating any underlying conditions in secondary livedo, [47] idiopathic livedo reticularis may improve with warming the area.

See also

Related Research Articles

<span class="mw-page-title-main">Vasculitis</span> Medical disorders that destroy blood vessels by inflammation

Vasculitis is a group of disorders that destroy blood vessels by inflammation. Both arteries and veins are affected. Lymphangitis is sometimes considered a type of vasculitis. Vasculitis is primarily caused by leukocyte migration and resultant damage. Although both occur in vasculitis, inflammation of veins (phlebitis) or arteries (arteritis) on their own are separate entities.

<span class="mw-page-title-main">Panniculitis</span> Medical condition

Panniculitis is a group of diseases whose hallmark is inflammation of subcutaneous adipose tissue. Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue.

<span class="mw-page-title-main">Polyarteritis nodosa</span> Medical condition

Polyarteritis nodosa (PAN) is a systemic necrotizing inflammation of blood vessels (vasculitis) affecting medium-sized muscular arteries, typically involving the arteries of the kidneys and other internal organs but generally sparing the lungs' circulation. Small aneurysms are strung like the beads of a rosary, therefore making this "rosary sign" an important diagnostic feature of the vasculitis. PAN is sometimes associated with infection by the hepatitis B or hepatitis C virus. The condition may be present in infants.

<span class="mw-page-title-main">Cryoglobulinemia</span> Medical condition

Cryoglobulinemia is a medical condition in which the blood contains large amounts of pathological cold sensitive antibodies called cryoglobulins – proteins that become insoluble at reduced temperatures. This should be contrasted with cold agglutinins, which cause agglutination of red blood cells.

Microscopic polyangiitis is an autoimmune disease characterized by a systemic, pauci-immune, necrotizing, small-vessel vasculitis without clinical or pathological evidence of granulomatous inflammation.

<span class="mw-page-title-main">Sneddon's syndrome</span> Medical condition

Sneddon's syndrome is a form of arteriopathy characterized by several symptoms, including:

<span class="mw-page-title-main">Cholesterol embolism</span> Medical condition

Cholesterol embolism occurs when cholesterol is released, usually from an atherosclerotic plaque, and travels as an embolus in the bloodstream to lodge causing an obstruction in blood vessels further away. Most commonly this causes skin symptoms, gangrene of the extremities and sometimes kidney failure; problems with other organs may arise, depending on the site at which the cholesterol crystals enter the bloodstream. When the kidneys are involved, the disease is referred to as atheroembolic renal disease. The diagnosis usually involves biopsy from an affected organ. Cholesterol embolism is treated by removing the cause and giving supportive therapy; statin drugs have been found to improve the prognosis.

Rheumatoid vasculitis is skin condition that is a typical feature of rheumatoid arthritis, presenting as peripheral vascular lesions that are localized purpura, cutaneous ulceration, and gangrene of the distal parts of the extremities.

<span class="mw-page-title-main">Systemic vasculitis</span> Medical condition

Necrotizing vasculitis, also called systemic necrotizing vasculitis, is a general term for the inflammation of veins and arteries that develops into necrosis and narrows the vessels.

<span class="mw-page-title-main">Livedoid dermatitis</span> Medical condition

Livedoid dermatitis is a iatrogenic cutaneous reaction that occurs immediately after a drug injection. It presents as an immediate, extreme pain around the injection site, with overlying skin rapidly becoming erythematous, violaceous, or blanched and sometimes with reticular pattern. The reaction eventually leads to variable degrees of necrosis to the skin and underlying tissue. The wound eventually heals, but can lead to atrophic, disfiguring scarring.

Cryofibrinogenemia refers to a condition classified as a fibrinogen disorder in which a person's blood plasma is allowed to cool substantially, causing the (reversible) precipitation of a complex containing fibrinogen, fibrin, fibronectin, and, occasionally, small amounts of fibrin split products, albumin, immunoglobulins and other plasma proteins.

<span class="mw-page-title-main">Cutaneous small-vessel vasculitis</span> Medical condition

Cutaneous small-vessel vasculitis (CSVV), is inflammation of small blood vessels, usually accompanied by small lumps beneath the skin. The condition is also known as hypersensitivity vasculitis, cutaneous leukocytoclastic vasculitis, hypersensitivity angiitis, cutaneous leukocytoclastic angiitis, cutaneous necrotizing vasculitis and cutaneous necrotizing venulitis,

<span class="mw-page-title-main">Livedoid vasculopathy</span> Medical condition

Livedoid vasculopathy(LV) is an uncommon thrombotic dermal vasculopathy that is characterized by excruciating, recurrent ulcers on the lower limbs. Livedo racemosa, a painful ulceration in the distal regions of the lower extremities, is the characteristic clinical appearance. It heals to form porcelain-white, atrophic scars, also known as Atrophie blanche.

<span class="mw-page-title-main">Behçet's disease</span> Inflammatory disorder

Behçet's disease (BD) is a type of inflammatory disorder which affects multiple parts of the body. The most common symptoms include painful sores on the mucous membranes of the mouth and other parts of the body, inflammation of parts of the eye, and arthritis. The sores can last from a few days, up to a week or more. Less commonly there may be inflammation of the brain or spinal cord, blood clots, aneurysms, or blindness. Often, the symptoms come and go.

Microvascular occlusion refers to conditions that can present with retiform purpura. It has been suggested that phenylephrine may be a cause.

<span class="mw-page-title-main">Lupus vasculitis</span> Medical condition

Lupus vasculitis is one of the secondary vasculitides that occurs in approximately 50% of patients with systemic lupus erythematosus (SLE).

<span class="mw-page-title-main">Adenosine deaminase 2 deficiency</span> Medical condition

Deficiency of Adenosine deaminase 2 (DADA2) is a monogenic disease associated with systemic inflammation and vasculopathy that affects a wide variety of organs in different patients. As a result, it is hard to characterize a patient with this disorder. Manifestations of the disease include but are not limited to recurrent fever, livedoid rash, various cytopenias, stroke, immunodeficiency, and bone marrow failure. Symptoms often onset during early childhood, but some cases have been discovered as late as 65 years old.

Cutaneous manifestations of COVID-19 are characteristic signs or symptoms of the Coronavirus disease 2019 that occur in the skin. The American Academy of Dermatology reports that skin lesions such as morbilliform, pernio, urticaria, macular erythema, vesicular purpura, papulosquamous purpura and retiform purpura are seen in people with COVID-19. Pernio-like lesions were more common in mild disease while retiform purpura was seen only in critically ill patients. The major dermatologic patterns identified in individuals with COVID-19 are urticarial rash, confluent erythematous/morbilliform rash, papulovesicular exanthem, chilbain-like acral pattern, livedo reticularis and purpuric "vasculitic" pattern. Chilblains and Multisystem inflammatory syndrome in children are also cutaneous manifestations of COVID-19.

Retiform purpura is the result of total vascular blockage and damage to the skin's blood vessels. The skin then shows lesions, appearing due to intravascular issues where clots, proteins, or emboli block skin vessels. They can also result from direct harm to the vessel walls, as seen in conditions like vasculitis, calciphylaxis, and certain severe opportunistic infections.

References

  1. Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. p. 1615. ISBN   978-1-4160-2999-1.
  2. "livedo reticularis" "at Dorland's Medical Dictionary
  3. Kroshinsky; Stone, John H.; Bloch, Donald B.; Sepehr, Alireza (February 2009). "Case 5-2009 — A 47-Year-Old Woman with a Rash and Numbness and Pain in the Legs". New England Journal of Medicine. 360 (7): 711–20. doi:10.1056/NEJMcpc0807822. PMID   19213685.
  4. James, William D.; Elston, Dirk; Treat, James R.; Rosenbach, Misha A.; Neuhaus, Isaac (2020). "35.Cutaneous vascular diseases". Andrews' Diseases of the Skin: Clinical Dermatology (13th ed.). Edinburgh: Elsevier. p. 817. ISBN   978-0-323-54753-6. Archived from the original on 2023-03-18. Retrieved 2023-03-18.
  5. Sundriyal, Deepak; Kumar, Naveen; Kumar, Gaurav; Walia, Meenu (15 May 2014). "Livedo reticularis heralding hypercalcaemia of malignancy". BMJ Case Reports. 2014 (may14 4): bcr2013201371. doi:10.1136/bcr-2013-201371. PMC   4024535 . PMID   24832704.
  6. Sneddon IB (April 1965). "Cerebro-Vascular Lesions And Livedo Reticularis". British Journal of Dermatology. 77 (4): 180–5. doi:10.1111/j.1365-2133.1965.tb14628.x. PMID   14278790. S2CID   43219068.
  7. Gibbs, Mark B.; English, Joseph C.; Zirwas, Matthew J. (2005). "Livedo reticularis: an update". J Am Acad Dermatol. 52 (6): 1009–19. doi:10.1016/j.jaad.2004.11.051. PMID   15928620.
  8. Feldaker M, Hines E, Kierland R (1955). "Livedo reticularis with summer ulcerations". AMA Arch Dermatol. 72 (1): 31–42. doi:10.1001/archderm.1955.03730310033007. PMID   14387292.
  9. Golden R (March 1963). "Livedo reticularis in systemic lupus erythematosus". Arch Dermatol. 87 (3): 299–301. doi:10.1001/archderm.1963.01590150015002. PMID   13948706.
  10. Sigmund W, Shelley W (1954). "Cutaneous manifestations of acute pancreatitis, with special reference to livedo reticularis". N Engl J Med. 251 (21): 851–3. doi:10.1056/NEJM195411182512104. PMID   13214346.
  11. Gould, Jennifer W.; Helms, Stephen E.; Schulz, Susan M.; Stevens, Seth R. (1998). "Relapsing livedo reticularis in the setting of chronic pancreatitis". Journal of the American Academy of Dermatology. 39 (6): 1035–1036. doi:10.1016/S0190-9622(98)70290-7. PMID   9843029.
  12. Rot, Uroš; Ledinek, Alenka Horvat (December 2013). "Interferons beta have vasoconstrictive and procoagulant effects: a woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis". Clinical Neurology and Neurosurgery. 115 (Suppl 1): S79–81. doi:10.1016/j.clineuro.2013.09.027. PMID   24321162. S2CID   11757438.
  13. Fox, Michelle; Tahan, Steven; Kim, Caroline C. (2012). "Livedo Reticularis: A Side Effect of Interferon Therapy in a Pediatric Patient with Melanoma". Pediatric Dermatology. 29 (3): 333–5. doi:10.1111/j.1525-1470.2011.01426.x. PMID   21575046. S2CID   37285113.
  14. Cruz, Boris Afonso; de Queiroz, Eustáquio; Nunes, Simone Vilela; Cruz Filho, Achiles; Campos, Gilberto Belisario; de Carvalho Monteiro, Ernesto Lentz; Crivellari, Humberto (2000). "Fênomeno de Raynaud grave associado a terapia com interferon-beta para esclerose múltipla: relato de caso" [Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report]. Arquivos de Neuro-Psiquiatria (in Portuguese). 58 (2B): 556–9. doi: 10.1590/S0004-282X2000000300025 . PMID   10920422.
  15. Strowd, Lindsay C.; Lee, Andrew D.; Yosipovitch, Gil (June 2012). "Livedo Reticularis Associated With Rasagiline (Azilect)". Journal of Drugs in Dermatology. 11 (6): 764–5. PMID   22648227. Archived from the original on 2021-03-05. Retrieved 2014-03-21.
  16. Syed, Reema H.; Moore, Terry L. (2008). "Methylphenidate and Dextroamphetamine-Induced Peripheral Vasculopathy". Journal of Clinical Rheumatology. 14 (1): 30–33. doi:10.1097/RHU.0b013e3181639aaa. PMID   18431096.
  17. Blume, Jonathan E.; Miller, Craig C. (2007). "Livedo reticularis with retiform purpura associated with gefitinib (Iressa®)". International Journal of Dermatology. 46 (12): 1307–8. doi:10.1111/j.1365-4632.2007.03319.x. PMID   18173531. S2CID   43388374.
  18. Langhof H, Braun G, Matzkowski H (1957). "Livedo reticularis durch Kältegelierung des Blutes bei γ-Plasmocytom" [Livedo reticularis due to cold gelation of the blood by gamma-plasmacytoma]. Archiv für Klinische und Experimentelle Dermatologie (in German). 205 (4): 343–50. doi:10.1007/BF00693523. PMID   13522017. S2CID   10434333.
  19. Kazmier F, Sheps S, Bernatz P, Sayre G (1966). "Livedo reticularis and digital infarcts: a syndrome due to cholesterol emboli arising from atheromatous abdominal aortic aneurysms". Vasc Dis. 3 (1): 12–24. PMID   5903590.
  20. Stewart W, Lauret P, Testart J, Thomine E, Boulliê M, Leroy D (1977). "Les manifestations cutanées des emoblies de critaux de cholestérol" [Cutaneous cholesterol emboli]. Ann Dermatol Venereol (in French). 104 (1): 5–8. PMID   843026.
  21. Buckley, Sarah A.; Lessing, Juan N.; Mark, Nicholas M. (2013). "Livedo Reticularis in a Patient with Pheochromocytoma Resolving After Adrenalectomy". The Journal of Clinical Endocrinology & Metabolism. 98 (2): 439–40. doi: 10.1210/jc.2012-2842 . PMID   23275529.
  22. Yong AA, Tan AW, Giam YC, Tang MB (December 2012). "Livedoid vasculopathy and its association with factor V Leiden mutation" (PDF). Singapore Med J. 53 (12): e258–60. PMID   23268168. Archived (PDF) from the original on 2016-03-04. Retrieved 2014-03-22.
  23. Pachlopnik Schmid, Jana; Lemoine; Nehme, Nadine; Cormier-Daire, Valéry; Revy, Patrick; Debeurme, Franck; Debré, Marianne; Nitschke, Patrick; Bole-Feysot, Christine; Legeai-Mallet, Laurence; Lim, Annick; de Villartay, Jean-Pierre; Picard, Capucine; Durandy, Anne; Fischer, Alain; de Saint Basile, Geneviève (2012). "Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature ('FILS syndrome')" (PDF). Journal of Experimental Medicine. 209 (13): 2323–30. doi:10.1084/jem.20121303. PMC   3526359 . PMID   23230001.
  24. Jorquera-Barquero, E.; Súarez-Marrero, M.C.; Fernández Girón, F.; Borrero Martín, J.J. (2013). "Oxalosis y livedo reticularis" [Oxalosis and Livedo Reticularis]. Actas Dermo-Sifiliográficas (in Spanish). 104 (9): 815–8. doi: 10.1016/j.ad.2012.04.019 . PMID   23103120.
  25. Bogle MA, Teller CF, Tschen JA, Smith CA, Wang A (October 2003). "Primary hyperoxaluria in a 27-year-old woman". J. Am. Acad. Dermatol. 49 (4): 725–8. doi:10.1067/s0190-9622(03)00119-1. PMID   14512927.
  26. Marconi V, Mofid MZ, McCall C, Eckman I, Nousari HC (February 2002). "Primary hyperoxaluria: report of a patient with livedo reticularis and digital infarcts". J. Am. Acad. Dermatol. 46 (2 Suppl Case Reports): S16–8. doi:10.1067/mjd.2002.105475. PMID   11807460.
  27. Shih HA, Kao DM, Elenitsas R, Leyden JJ (October 2000). "Livedo reticularis, ulcers, and peripheral gangrene: cutaneous manifestations of primary hyperoxaluria". Arch Dermatol. 136 (10): 1272–4. doi:10.1001/archderm.136.10.1272-a (inactive 2024-02-01). PMID   11030785. S2CID   32702914.{{cite journal}}: CS1 maint: DOI inactive as of February 2024 (link)
  28. Singh S, Tai C, Ganz G, et al. (April 1999). "Steroid-responsive pleuropericarditis and livedo reticularis in an unusual case of adult-onset primary hyperoxaluria". Am. J. Kidney Dis. 33 (4): e5.1–e5.6. doi:10.1016/s0272-6386(99)70246-5. PMID   10196036.
  29. Arslan, Ferhat; Batirel, Ayse; Mert, Ali; Ozer, Serdar (2012). "Cytomegalovirus (CMV)-related cutaneous necrotizing vasculitis: Case report and literature review". The Brazilian Journal of Infectious Diseases. 16 (5): 482–5. doi: 10.1016/j.bjid.2012.08.002 . PMID   22975173.
  30. Camacho, Diana; Machan, Shalma; Pilesanski, Ursula; Revelles, Juan Maria; Martín, Lucia; Requena, Luis (2012). "Generalized Livedo Reticularis Induced by Silicone Implants for Soft Tissue Augmentation". The American Journal of Dermatopathology. 34 (2): 203–7. doi:10.1097/DAD.0b013e31821cb3c5. PMID   22441370.
  31. Bilgili SG, Akdeniz N, Karadag AS, Akbayram S, Calka O, Ozkol HU (2011). "Mucocutaneous disorders in children with down syndrome: case-controlled study". Genet. Couns. 22 (4): 385–92. PMID   22303799.
  32. Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M (2007). "Mucocutaneous findings in 100 children with Down syndrome". Pediatr Dermatol. 24 (3): 317–20. doi:10.1111/j.1525-1470.2007.00412.x. PMID   17542890. S2CID   25151006.
  33. ENDO, Yuichiro; MIYACHI, Yoshiki; YOSHIKAWA, Yoshiaki (2011). "John Libbey Eurotext : Éditions médicales et scientifiques France : revues, médicales, scientifiques, médecine, santé, livres". European Journal of Dermatology. Jle.com. 21 (2): 266–7. doi:10.1684/ejd.2010.1226. PMID   21489905.
  34. Johnson, Philip L.; Neperud, Julie; Arnold, Jill; Thomas, James (2011). "Livedo Reticularis and Bowel Ischemia after Carbon Dioxide Arteriography in a Patient with CREST Syndrome". Journal of Vascular and Interventional Radiology. 22 (3): 395–9. doi:10.1016/j.jvir.2010.11.012. PMID   21277800.
  35. Bosco, Laura; Peroni, Anna; Schena, Donatella; Colato, Chiara; Girolomoni, Giampiero (2010). "Cutaneous manifestations of Churg–Strauss syndrome: Report of two cases and review of the literature". Clinical Rheumatology. 30 (4): 573–80. doi:10.1007/s10067-010-1593-1. PMID   20949297. S2CID   24158646.
  36. Yamamoto, Toshiyuki; Takenoshita, Hideo (September 2010). "John Libbey Eurotext : Éditions médicales et scientifiques France : revues, médicales, scientifiques, médecine, santé, livres". European Journal of Dermatology. Jle.com. 20 (5): 640–641. doi:10.1684/ejd.2010.1034 (inactive 31 January 2024). PMID   20610374. Archived from the original on 2014-02-16. Retrieved 2014-03-19.{{cite journal}}: CS1 maint: DOI inactive as of January 2024 (link)
  37. 1 2 Tabata, N; Oonami, K; Ishibashi, M; Yamazaki, M (2010). "Livedo Vasculopathy Associated with IgM Anti-phosphatidylserine-prothrombin Complex Antibody". Acta Dermato Venereologica. 90 (3): 313–4. doi: 10.2340/00015555-0835 . PMID   20526560.
  38. Gambichler, T.; Baier, P.; Altmeyer, P. (2009). "Generalized livedo reticularis as the first sign of metastatic breast carcinoma". Clinical and Experimental Dermatology. 34 (2): 253–4. doi:10.1111/j.1365-2230.2008.02801.x. PMID   19120398. S2CID   1965405.
  39. Erel, Arzu; Ozsoy, Esra; University, Gazi (2001). "Livedo reticularis associated with renal cell carcinoma". International Journal of Dermatology. 40 (4): 299–300. doi:10.1046/j.1365-4362.2001.00895.x. PMID   11454094. S2CID   46560722.
  40. Takanashi, Tetsuo; Horigome, Reiko; Okuda, Yasuaki; Nose, Masato; Matsuda, Masayuki; Ikeda, Shu-Ichi (2007). "Buerger's Disease Manifesting Nodular Erythema with Livedo Reticularis". Internal Medicine. 46 (21): 1815–9. doi: 10.2169/internalmedicine.46.0143 . PMID   17978541.
  41. Liel Y (June 2004). "Livedo reticularis: a rare manifestation of Graves hyperthyroidism associated with anticardiolipin antibodies". South. Med. J. 97 (6): 601–3. doi:10.1097/00007611-200406000-00019. PMID   15255431.
  42. Bandyopadhyay, D. (2003). "Celecoxib-induced fixed drug eruption". Clinical and Experimental Dermatology. 28 (4): 452. doi:10.1046/j.1365-2230.2003.01285_5.x. PMID   12823316. S2CID   33331314.
  43. Richards, Kristen A.; Paller, Amy S. (2003). "Livedo Reticularis in a Child with Moyamoya Disease". Pediatric Dermatology. 20 (2): 124–7. doi:10.1046/j.1525-1470.2003.20205.x. PMID   12657007. S2CID   20135035.
  44. Shrestha NK, Gordon SM, Isada CM (2002). "Livedo reticularis associated with the use of a midline catheter". Scand. J. Infect. Dis. 34 (11): 845–6. doi:10.1080/0036554021000026942. PMID   12578157. S2CID   42667906.
  45. van Geest AJ, van Dooren-Greebe RJ, Andriessen MP, Blomjous CE, Go IH (January 1999). "Familial primary cryofibrinogenemia". J Eur Acad Dermatol Venereol. 12 (1): 47–50. doi:10.1111/j.1468-3083.1999.tb00808.x. PMID   10188150. S2CID   23748363.
  46. Ngan, Vanessa (September 2016). Oakley, Amanda (ed.). "Livedo reticularis". DermNet NZ. Archived from the original on February 4, 2018. Retrieved February 2, 2018.
  47. Fleischer A, Resnick S (1990). "Livedo reticularis". Dermatol Clin. 8 (2): 347–54. doi:10.1016/S0733-8635(18)30506-0. PMID   2191805.